GPT and COVID-19: To assess the AST/ALT ratio on poor prognosis of patients with different liver enzyme levels23, we separated the 555 COVID-19 patients with clear survival data (recovery or death) into two groups according to their AST levels (≤ 40 or > 40 U/L) on admission (Table 5).